Skip to main content

Advertisement

Log in

Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Background

Hereditary motor and sensory neuropathy type Ia (HMSN Ia) is known as a primarily demyelinating peripheral nerve disease. Evidence is accumulating that axonal involvement determines the course of the disease process.

Methods

Fifty-one patients were investigated. Physical disability and impairments were scored. Nerve conduction velocities (NCVs) were used as indirect measures for myelination status and compound muscle/sensory nerve action potential (CMAP/SNAP) amplitudes served as indirect measures for axonal function.

Results

Median age was 39 years (range 6–69).Muscle weakness and sensory dysfunction was more severe in the legs than in the arms and distally more than proximally. However, more than 40% of the patients had proximal muscle weakness in the legs. Three point grip was used as representative of combined distal arm muscle groups. CMAP amplitude was the most important independent variable in a multiple linear regression model (forward selection) to explain the relation between three point grip strength and four different features, i. e., CMAP amplitude of the abductor pollicis brevis, median nerve MNCV, gender, and duration of signs and symptoms. The severity of axonal dysfunction was nerve length-dependent and was related to the myelination status. The mild physical disability due to both muscle weakness and sensory dysfunction was also related to axonal dysfunction.

Conclusions

In HMSN Ia, clinical disease severity at the impairment and disability levels is related to the severity of axonal dysfunction. Our data support the hypothesis that the myelination status is one of the factors that determine the extent of axonal dysfunction later in life. Proximal weakness of the legs is encountered in a considerable proportion of our patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beenakker EA, Van der Hoeven JH, Fock JM, Maurits NM (2001) Reference values of maximum isometric muscle force obtained in 270 children aged 4–16 years by hand-held dynamometry. Neuromuscul Disord 11:441–446

    Google Scholar 

  2. Berciano J, Garcia A, Calleja J, Combarros O (2000) Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot-Marie-Tooth disease 1A duplication. Neuromuscul Disord 10:419–424

    Google Scholar 

  3. Bergner M, Bobbitt RA, Carter WB, Gilson BS (1981) The Sickness Impact Profile: development and final revision of a health status measure. Med Care 19:787–805

    CAS  PubMed  Google Scholar 

  4. Birouk N, Gouider R, Le Guern E, Gugenheim M, Tardieu S, Maisonobe T, Le Forestier N, Agid Y, Brice A, Bouche P (1997) Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 120:813–823

    Google Scholar 

  5. De Waegh S, Brady ST (1990) Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the Trembler as an in vivo model for Schwann cell-axon interactions. J Neurosci 10:1855–1865

    Google Scholar 

  6. De Waegh SM, Lee VMY, Brady ST (1992) Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68:451–463

    Google Scholar 

  7. Dyck PJ, Karnes JL, Lambert EH (1989) Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology 39:1302–1308

    Google Scholar 

  8. Dyck PJ, Swanson CJ, Low PA, Bartleson JD, Lambert EH (1982) Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc 57:239–246

    CAS  PubMed  Google Scholar 

  9. Gabreëls-Festen AA, Joosten EM, Gabreëls FJ, Jennekens FG, Janssen-van Kempen TW (1992) Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I). J Neurol Sci 107:145–154

    Article  CAS  PubMed  Google Scholar 

  10. Gabriel CM, Gregson NA, Wood NW, Hughes RA (2002) Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a). J Neurol Neurosurg Psychiatry 72:230–235

    Google Scholar 

  11. Garcia A, Combarros O, Calleja J, Berciano J (1998) Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study. Neurology 50:1061–1067

    Google Scholar 

  12. Ginsberg L, Malik O, Kenton AR, Sharp D, Muddle JR, Davis MB, Winer JB, Orrell RW, King RH (2004) Coexistent hereditary and inflammatory neuropathy. Brain 127:193–202

    Article  PubMed  Google Scholar 

  13. Gutmann L, Fakadej A, Riggs JE (1983) Evolution of nerve conduction abnormalities in children with dominant hypertrophic neuropathy of the Charcot-Marie-Tooth type. Muscle Nerve 6:515–519

    Google Scholar 

  14. Harding AE, Thomas PK (1980) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259–280

    Google Scholar 

  15. Hattori N, Yamamoto M, Yoshihara T, Koike H, Nakagawa M, Yoshikawa H, Ohnishi A, Hayasaka K, Onodera O, Baba M, Yasuda H, Saito T, Nakashima K, Kira JI, Kaji R, Oka N, Sobue G (2003) Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain 126:134–151

    Google Scholar 

  16. Hoogendijk JE, De Visser M, Bolhuis PA, Hart AA, Ongerboer de Visser BW (1994) Hereditary motor and sensory neuropathy type I: clinical and neurographical features of the 17p duplication subtype. Muscle Nerve 17:85–90

    Google Scholar 

  17. Hoogerwaard EM, Bakker E, Ippel PF, Oosterwijk JC, Majoor-Krakauer DF, Leschot NJ, Van Essen AJ, Brunner HG, Van der Wouw PA, Wilde AA, De Visser M (1999) Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet 353:2116–2119

    Google Scholar 

  18. Jacobs HM, Luttik A, Touw-Otten FW, de Melker RA (1990) The sickness impact profile; results of an evaluation study of the Dutch version. Ned Tijdschr Geneeskd 134:1950–1954

    Google Scholar 

  19. Kets CM, Van Leerdam ME, Van Brakel WH, Deville W, Bertelsmann FW (1996) Reference values for touch sensibility thresholds in healthy Nepalese volunteers. Lepr Rev 67:28–38

    Google Scholar 

  20. Killian JM, Tiwari PS, Jacobson S, Jackson RD, Lupski JR (1996) Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy. Muscle Nerve 19:74–78

    Google Scholar 

  21. Kimura J (1993) Nerve conduction studies and electromyography. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds). Peripheral neuropathy. WB, Saunders, Philadelphia, pp 598–635

  22. Kimura J, Machida M, Ishida T, Yamada T, Rodnitzky RL, Kudo Y, Suzuki S (1986) Relation between size of compound sensory or muscle action potentials, and length of nerve segment. Neurology 36:647–652

    Google Scholar 

  23. Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, Kamholz J, Shy ME (2000) Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 123:1516–1527

    Google Scholar 

  24. Lewis RA, Li J, Fuerst DR, Shy ME, Krajewski K (2003) Motor unit number estimate of distal and proximal muscles in Charcot-Marie-Tooth disease. Muscle Nerve 28:161–167

    Google Scholar 

  25. Lupski JR, Oca-Luna RM, Slaugenhaupt S, Pentao L,Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66:219–232

    Article  CAS  PubMed  Google Scholar 

  26. Merkies IS, Schmitz PI, Van der Meché FG, Samijn JP, Van Doorn PA (2002) Psychometric evaluation of a new handicap scale in immune-mediated polyneuropathies. Muscle Nerve 25:370–377

    Google Scholar 

  27. Merkies IS, Schmitz PI, Van der Meché FG, Van Doorn PA (2000) Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 54:943–949

    Google Scholar 

  28. Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, Barker DF,Martin JJ,De Visser M, Bolhuis PA (1991) Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord 1:93–97

    Google Scholar 

  29. Reilly MM, Hanna MG (2002) Genetic neuromuscular disease. J Neurol Neurosurg Psychiatry 73 Suppl 2:II12–II21

    Google Scholar 

  30. Ritz MF, Lechner-Scott J, Scott RJ, Fuhr P, Malik N, Erne B, Taylor V, Suter U, Schaeren-Wiemers N, Steck AJ (2000) Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies. J Neuroimmunol 104:155–163

    Google Scholar 

  31. Robaglia-Schlupp A, Pizant J, Norreel JC, Passage E, Saberan-Djoneidi D, Ansaldi JL, Vinay L, Figarella-Branger D, Levy N, Clarac F, Cau P, Pellissier JF, Fontes M (2002) PMP22 overexpression causes dysmyelination in mice. Brain 125:2213–2221

    Google Scholar 

  32. Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiology 1:43–46

    CAS  PubMed  Google Scholar 

  33. Roy EP, Gutmann L, Riggs JE (1989) Longitudinal conduction studies in hereditary motor and sensory neuropathy type 1. Muscle Nerve 12:52–55

    Google Scholar 

  34. Rudnik-Schoneborn S, Rohrig D, Nicholson G, Zerres K (1993) Pregnancy and delivery in Charcot-Marie-Tooth disease type 1. Neurology 43:2011–2016

    Google Scholar 

  35. Sahenk Z, Chen L, Mendell JR (1999) Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol 45:16–24

    Google Scholar 

  36. Schmid CD, Stienekemeier M, Oehen S, Bootz F, Zielasek J, Gold R, Toyka KV, Schachner M, Martini R (2000) Immune Deficiency in Mouse Models for Inherited Peripheral Neuropathies Leads to Improved Myelin Maintenance. J Neurosci 20:729–735

    Google Scholar 

  37. Sharrack B, Hughes RA (1999) Scale development and Guy’s Neurological Disability Scale. J Neurol 246:226

    Google Scholar 

  38. Shy ME, Garbern JY, Kamholz J (2002) Hereditary motor and sensory neuropathies: a biological perspective. Lancet Neurol 1:110–118

    Google Scholar 

  39. Thomas PK, Marques W Jr, Davis MB, Sweeney MG, King RH, Bradley JL, Muddle JR, Tyson J, Malcolm S, Harding AE (1997) The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 120:465–478

    Google Scholar 

  40. Tjon-A-Tsien AML, Lemkes HHPJ, Van der Kamp-Huyts AJC, Van Dijk JG (1996) Large electrodes improve nerve conduction repeatability in controls as well as in patients with diabetic neuropathy. Muscle Nerve 19:689–695

    Google Scholar 

  41. Van der Ploeg RJ, Fidler V, Oosterhuis HJ (1991) Hand-held myometry: reference values. J Neurol Neurosurg Psychiatry 54:244–247

    Google Scholar 

  42. Van Dijk JG, Van der Kamp WIM, Van Hilten BJ, Van Someren P (1994) Influence of recording site on CMAP amplitude on its variation over a length of nerve. Muscle Nerve 17:1286–1292

    Google Scholar 

  43. Vital A, Vital C, Lagueny A, Ferrer X, Ribiere-Bachelier C, Latour P, Petry KG (2003) Inflammatory demyelination in a patient with CMT1A. Muscle Nerve 28:373–376

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Camiel Verhamme.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verhamme, C., van Schaik, I.N., Koelman, J.H.T.M. et al. Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia. J Neurol 251, 1491–1497 (2004). https://doi.org/10.1007/s00415-004-0578-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-004-0578-x

Key words

Navigation